Clinical Trials Directory

Trials / Completed

CompletedNCT01552655

Breast Cancer Recurrence - the Accuracy of Dual-time PET/CT

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
101 (actual)
Sponsor
Odense University Hospital · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to elucidate the value of dual-time-point PET/CT in the recurrence of breast cancer and to determine whether the method is better than the modalities used in the standard work up. 150 patients with suspected breast cancer recurrence will be included. All patients will undergo dual-time-point PET/CT, CT of thorax and upper abdomen and bone scintigraphy. After completion of the examinations the early and the late PET/CT scan will be compared with each other, the diagnostic CT-scan and the bone scintigraphy. A verification of suspicious findings will be done by biopsy, if the area is accessible. If a biopsy cannot be obtained, the presence of recurrence will be verified with additional imaging follow-up to ensure the highest possible confidence. Sensitivity, specificity, accuracy, negative and positive predictive value (NPV/PPV) will be calculated for each modality (incl. early and late PET/CT).

Conditions

Interventions

TypeNameDescription
RADIATIONDual-time PET/CT (low-dose)4 MBq/kg 18F-flour-deoxyglucose administered iv. PET/CT-scans performed 60 min and 180 min after injection.

Timeline

Start date
2011-12-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2012-03-13
Last updated
2015-04-21

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01552655. Inclusion in this directory is not an endorsement.